Medical - Devices
Compare Stocks
2 / 10Stock Comparison
NNOX vs NVDA
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
NNOX vs NVDA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Semiconductors |
| Market Cap | $117M | $5.05T |
| Revenue (TTM) | $12M | $215.94B |
| Net Income (TTM) | $-56M | $120.07B |
| Gross Margin | -98.8% | 71.1% |
| Operating Margin | -469.7% | 60.4% |
| Forward P/E | — | 25.1x |
| Total Debt | $7M | $11.41B |
| Cash & Equiv. | $39M | $10.61B |
NNOX vs NVDA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 20 | May 26 | Return |
|---|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | 100 | 3.9 | -96.1% |
| NVIDIA Corporation (NVDA) | 100 | 1590.1 | +1490.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NNOX vs NVDA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NNOX is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.86, Low D/E 3.9%, current ratio 5.63x
NVDA carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 1.73, yield 0.0%
- Rev growth 65.5%, EPS growth 66.7%, 3Y rev CAGR 100.0%
- 234.3% 10Y total return vs NNOX's -96.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 65.5% revenue growth vs NNOX's 13.9% | |
| Quality / Margins | 55.6% margin vs NNOX's -452.8% | |
| Stability / Safety | Beta 1.73 vs NNOX's 1.86 | |
| Dividends | 0.0% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +82.9% vs NNOX's -63.7% | |
| Efficiency (ROA) | 58.1% ROA vs NNOX's -31.6%, ROIC 81.8% vs -27.9% |
NNOX vs NVDA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NNOX vs NVDA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NVDA leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NVDA is the larger business by revenue, generating $215.9B annually — 17553.1x NNOX's $12M. NVDA is the more profitable business, keeping 55.6% of every revenue dollar as net income compared to NNOX's -4.5%. On growth, NVDA holds the edge at +73.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $12M | $215.9B |
| EBITDAEarnings before interest/tax | -$46M | $133.2B |
| Net IncomeAfter-tax profit | -$56M | $120.1B |
| Free Cash FlowCash after capex | -$47M | $96.7B |
| Gross MarginGross profit ÷ Revenue | -98.8% | +71.1% |
| Operating MarginEBIT ÷ Revenue | -4.7% | +60.4% |
| Net MarginNet income ÷ Revenue | -4.5% | +55.6% |
| FCF MarginFCF ÷ Revenue | -3.8% | +44.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.7% | +73.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +8.7% | +97.8% |
Valuation Metrics
NNOX leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $117M | $5.05T |
| Enterprise ValueMkt cap + debt − cash | $85M | $5.05T |
| Trailing P/EPrice ÷ TTM EPS | -1.97x | 42.38x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 25.09x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.44x |
| EV / EBITDAEnterprise value multiple | — | 37.89x |
| Price / SalesMarket cap ÷ Revenue | 10.37x | 23.37x |
| Price / BookPrice ÷ Book value/share | 0.55x | 32.26x |
| Price / FCFMarket cap ÷ FCF | — | 52.21x |
Profitability & Efficiency
NVDA leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
NVDA delivers a 76.3% return on equity — every $100 of shareholder capital generates $76 in annual profit, vs $-36 for NNOX. NNOX carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to NVDA's 0.07x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -35.5% | +76.3% |
| ROA (TTM)Return on assets | -31.6% | +58.1% |
| ROICReturn on invested capital | -27.9% | +81.8% |
| ROCEReturn on capital employed | -28.4% | +97.2% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 |
| Debt / EquityFinancial leverage | 0.04x | 0.07x |
| Net DebtTotal debt minus cash | -$32M | $807M |
| Cash & Equiv.Liquid assets | $39M | $10.6B |
| Total DebtShort + long-term debt | $7M | $11.4B |
| Interest CoverageEBIT ÷ Interest expense | -379.29x | 545.03x |
Total Returns (Dividends Reinvested)
NVDA leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NVDA five years ago would be worth $143,108 today (with dividends reinvested), compared to $604 for NNOX. Over the past 12 months, NVDA leads with a +82.9% total return vs NNOX's -63.7%. The 3-year compound annual growth rate (CAGR) favors NVDA at 92.4% vs NNOX's -52.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -36.7% | +10.0% |
| 1-Year ReturnPast 12 months | -63.7% | +82.9% |
| 3-Year ReturnCumulative with dividends | -89.1% | +612.7% |
| 5-Year ReturnCumulative with dividends | -94.0% | +1331.1% |
| 10-Year ReturnCumulative with dividends | -96.0% | +23433.1% |
| CAGR (3Y)Annualised 3-year return | -52.2% | +92.4% |
Risk & Volatility
NVDA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NVDA is the less volatile stock with a 1.73 beta — it tends to amplify market swings less than NNOX's 1.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVDA currently trades 95.8% from its 52-week high vs NNOX's 30.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.86x | 1.73x |
| 52-Week HighHighest price in past year | $5.86 | $216.80 |
| 52-Week LowLowest price in past year | $1.66 | $110.82 |
| % of 52W HighCurrent price vs 52-week peak | +30.5% | +95.8% |
| RSI (14)Momentum oscillator 0–100 | 38.5 | 50.8 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 166.2M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates NNOX as "Buy" and NVDA as "Buy". Consensus price targets imply 905.6% upside for NNOX (target: $18) vs 34.3% for NVDA (target: $279).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $18.00 | $278.83 |
| # AnalystsCovering analysts | 5 | 79 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% |
| Dividend StreakConsecutive years of raises | — | 2 |
| Dividend / ShareAnnual DPS | — | $0.04 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.8% |
NVDA leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NNOX leads in 1 (Valuation Metrics).
NNOX vs NVDA: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is NNOX or NVDA a better buy right now?
For growth investors, NVIDIA Corporation (NVDA) is the stronger pick with 65.
5% revenue growth year-over-year, versus 13. 9% for Nano-X Imaging Ltd. (NNOX). NVIDIA Corporation (NVDA) offers the better valuation at 42. 4x trailing P/E (25. 1x forward), making it the more compelling value choice. Analysts rate Nano-X Imaging Ltd. (NNOX) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — NNOX or NVDA?
Over the past 5 years, NVIDIA Corporation (NVDA) delivered a total return of +1331%, compared to -94.
0% for Nano-X Imaging Ltd. (NNOX). Over 10 years, the gap is even starker: NVDA returned +234. 3% versus NNOX's -96. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — NNOX or NVDA?
By beta (market sensitivity over 5 years), NVIDIA Corporation (NVDA) is the lower-risk stock at 1.
73β versus Nano-X Imaging Ltd. 's 1. 86β — meaning NNOX is approximately 8% more volatile than NVDA relative to the S&P 500. On balance sheet safety, Nano-X Imaging Ltd. (NNOX) carries a lower debt/equity ratio of 4% versus 7% for NVIDIA Corporation — giving it more financial flexibility in a downturn.
04Which is growing faster — NNOX or NVDA?
By revenue growth (latest reported year), NVIDIA Corporation (NVDA) is pulling ahead at 65.
5% versus 13. 9% for Nano-X Imaging Ltd. (NNOX). On earnings-per-share growth, the picture is similar: NVIDIA Corporation grew EPS 66. 7% year-over-year, compared to 15. 7% for Nano-X Imaging Ltd.. Over a 3-year CAGR, NNOX leads at 105. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — NNOX or NVDA?
NVIDIA Corporation (NVDA) is the more profitable company, earning 55.
6% net margin versus -474. 3% for Nano-X Imaging Ltd. — meaning it keeps 55. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVDA leads at 60. 4% versus -502. 9% for NNOX. At the gross margin level — before operating expenses — NVDA leads at 71. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is NNOX or NVDA more undervalued right now?
Analyst consensus price targets imply the most upside for NNOX: 905.
6% to $18. 00.
07Which pays a better dividend — NNOX or NVDA?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is NNOX or NVDA better for a retirement portfolio?
For long-horizon retirement investors, NVIDIA Corporation (NVDA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+234.
3% 10Y return). Nano-X Imaging Ltd. (NNOX) carries a higher beta of 1. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NVDA: +234. 3%, NNOX: -96. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between NNOX and NVDA?
These companies operate in different sectors (NNOX (Healthcare) and NVDA (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NNOX is a small-cap quality compounder stock; NVDA is a mega-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.